Last €75.48 EUR
Change Today +0.71 / 0.95%
Volume 2.1M
SAN On Other Exchanges
Symbol
Exchange
EN Paris
New York
BrsaItaliana
Mexico
EN Paris
Frankfurt
Frankfurt
NASDAQ GM
As of 11:39 AM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Arthur Charles Valerian Wellesley

Independent Director and Member of Appointments & Governance Committee, Sanofi
AgeTotal Calculated CompensationThis person is connected to 69 board members in 4 different organizations across 5 different industries.

See Board Relationships
68€104,000

Background*

Lord Arthur Charles Valerian Wellesley, Douro serves as Senior Advisor of Calyon (United Kingdom). Lord Wellesley serves as a Senior Advisor to the Credit Agricole Group. He has broad experience in banking and finance. He serves as the Chairman of Richemont Holdings (UK) Limited. He serves as Chairman of Kings College London (United Kingdom). He served as the Chairman of Framlington Group from 1994 to 2005. He served as Chairman of Sun Life and Provincial Holdings from ...

Read Full Background

Corporate Headquarters*

54, Rue La Boétie
Paris, Ile-de-France 75008

France

Phone: 33 1 53 77 40 00
Fax: --

Board Members Memberships*

2000-Present
Non-Executive Director, Member of Nominations Committee and Member of Compensation Committee
2002-Present
Independent Director and Member of Appointments & Governance Committee
2003-N/A
Former Independent Director
2010-Present
Non Executive Independent Director, Chairman of Remuneration Committee, Chairman of Conflicts Committee, Member of Nominations Committee and Member of Audit & Risk Committee

Education*

MA
University of Oxford

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation€104,000
Total Calculated Compensation€104,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SAN:FP €75.48 EUR +0.71

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.9M GBP
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
$1.5M
Lars Rebien Sørensen Chief Executive Officer and Member of the Senior Management Board
Novo Nordisk A/S
kr11.3M
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SANOFI, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.